Concepedia

Author

Philippe Kestemont

Centre Hospitalier d'ArrasORCID

Also Known As

P KESTEMONT, P Kestemont, P. Kestemont, Philippe Kestemont

49

Publications

734

Citations

15

H-Index

20

Concepts

All Affiliations

Centre Hospitalier d'ArrasCentre Hospitalier Universitaire de NiceCentre Hospitalier de CannesIpsen (France)Hôpital Pasteur
PK

About

Philippe Kestemont is an author at Centre Hospitalier d'Arras specializing in medicine, clinical trials, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

293

2

Pharmacology

2

2

48

3

Health Sciences

1

1

19

4

Diagnostic Sciences

1

1

19

5

Orthopaedics

1

1

25

Philippe Kestemont

×

20

Publications

662

Citations

15

H-Index

YearCitations

A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines

Benjamin Ascher, Benjamin Zakine, Philippe Kestemont,

Journal of the American Academy of Dermatology

2004

182

Full-Face Rejuvenation Using a Range of Hyaluronic Acid Fillers: Efficacy, Safety, and Patient Satisfaction over 6 Months

Berthold Rzany, Hugues Cartier, Philippe Kestemont,

Dermatologic Surgery

2012

81

Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of severe nasolabial lines - 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study

Benjamin Ascher, Christiane Bayerl, Patrick Brun,

Journal of Cosmetic Dermatology

2011

55

Botulinum toxin A in the treatment of glabellar lines: Scheduling the next injection

Benjamin Ascher, Benjamin Zakine, Philippe Kestemont,

Aesthetic Surgery Journal

2005

55

Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines

Benjamin Ascher, Berthold Rzany, Philippe Kestemont,

Aesthetic Surgery Journal

2019

29

Liquid Formulation of AbobotulinumtoxinA Exhibits a Favorable Efficacy and Safety Profile in Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trial

Benjamin Ascher, Philippe Kestemont, Dominique Boineau,

Aesthetic Surgery Journal

2017

27

A 12-Month Follow-up, Randomized Comparison of Effectiveness and Safety of Two Hyaluronic Acid Fillers for Treatment of Severe Nasolabial Folds

Benjamin Ascher, Christiane Bayerl, Philippe Kestemont,

Dermatologic Surgery

2016

25

Repeated Full-Face Aesthetic Combination Treatment With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin-Boosting Hyaluronic Acid After Monotherapy With AbobotulinumtoxinA or Hyaluronic Acid Filler

Hugues Cartier, Per Hedén, Henry Delmar,

Dermatologic Surgery

2019

23

Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial

Benjamin Ascher, Berthold Rzany, Philippe Kestemont,

Aesthetic Surgery Journal

2019

21

Sustained efficacy and high patient satisfaction after cheek enhancement with a new hyaluronic acid dermal filler.

Philippe Kestemont, Hugues Cartier, Patrick Trévidic,

PubMed

2012

20

Page 1